Quibim's AI software for prostate MRI cleared by FDA

By AuntMinnieEurope.com staff writers

March 5, 2021 -- Quibim's qp-Prostate artificial intelligence software for analyzing prostate MRI images has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Quibim's qp-Prostate software. Image courtesy of Quibim.

The imaging processing software product runs on off-the-shelf workstations, providing visualization and analysis of DICOM data to trained professionals. It enables automated segmentation of regions of the prostate, including the transitional zone, peripheral zone, and seminal vesicles, to aid in image interpretation and diagnoses, according to the company, which is based in Valencia, Spain.

Copyright © 2021 AuntMinnieEurope.com

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking